Skip to main content

Home

Home

AMRH Site Header Menu

  • Home
  • Who We Are
  • Our Focus
    • African Medicines Agency
    • AMRH Technical Committees
      • ABRF TC
      • AVAREF-TC
      • AMDF-TC
      • AMQF
      • IMS-TC
      • EMP-TC
      • GMP TC
      • MPRR-TC
      • RCD-TC
    • RCOREs
    • AMRH Partnership Platform
  • What We Do
  • Resources
    • FRPath® Project.
SEARCH BY
Lesotho Lesotho

Official Name: Kingdom of Lesotho
Capital: Maseru
Independence Day: 4 October 1966
Currency: Loti (LSL)

  • Indicators

Indicators

Regulatory Authority

As at 2008, there were no legal provisions that require establishing the powers and responsibilities of the Medicines Regulatory Authority. There are also no legal provisions that require marketing authorization (registration) for all pharmaceutical products on the market.

Inspection

In Lesotho, legal provisions exist allowing for appointment of government pharmaceutical inspectors. Legal provisions exist, permitting inspectors to inspect premises where pharmaceutical activities are performed. Such inspections are not required by law but are a pre-requisite for the licensing of private facilities. Where inspections are legal requirements, these are not the same for public and private facilities.

Pharmacovigilance

In Lesotho, there are no legal provisions in the Medicines Act that provide for pharmacovigilance activities as part of the MRA mandate. Legal provisions do not exist either requiring the Marketing Authorization holder to continuously monitor the safety of their products and report to the MRA. Laws regarding the monitoring of Adverse Drug Reactions (ADR) do not exist in Lesotho. A national pharmacovigilance centre linked to the MRA does not exist (World Health Organization, 2011).

AMRH Site Header Menu

  • Home
  • Who We Are
  • Our Focus
  • What We Do
  • Resources

CONNECT WITH US

Copyright © 2022 African Union Development Agency (AUDA-NEPAD). All rights reserved. | Terms & Conditions | Fraud Alert